BALAXI PHARMACEUTICALS
|
The Current P/E Ratio of BALAXI PHARMACEUTICALS is 13.40.
Share Price | ₹110.3 | Sep 13,2024 |
Market Cap | ₹608.7 Cr | |
Earnings-TTM | ₹45.4 Cr | TTM-Consolidated Results |
Price/Earnings | 13.40x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹608.7 Cr] as on Sep 13,2024
(/) Earnings [ ₹45.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 13.40x ]
Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 13.40 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS
PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS
- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.11x.
- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.
- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?
Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BALAXI PHARMACEUTICALS | 45.44 | 13.40 | 608.7 |
ADANI ENTERPRISES LTD | 4,226.98 | 80.06 | 338,421.0 |
REDINGTON LTD | 1,200.45 | 12.43 | 14,920.2 |
HONASA CONSUMER LTD | 126.07 | 127.14 | 16,028.4 |
MMTC LTD | 96.91 | 147.28 | 14,272.5 |
MSTC LTD | 222.51 | 23.29 | 5,182.1 |
LLOYDS ENTERPRISES LTD | 176.79 | 29.87 | 5,280.6 |
VERITAS (INDIA) LTD | 209.79 | 12.25 | 2,570.1 |
NOVARTIS INDIA LTD | 90.67 | 29.22 | 2,649.8 |
OPTIEMUS INFRACOM LTD | 57.46 | 97.56 | 5,605.6 |
MISHTANN FOODS LTD | 11.11 | 146.02 | 1,622.9 |
Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 12.25x |
Max industry PE | 147.28x |
Median industry PE | 29.87x |
Average industry PE | 65.32x |
You may also like the below Video Courses